Testing effectiveness (Phase 2)Ended earlyNCT03616821
What this trial is testing
Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis
Who this might be right for
Ulcerative ColitisIBD
AstraZeneca 242